CVS Caremark to cover Foundayo, Zepbound obesity drugs

UPI UPI

https://cdnph.upi.com/ph/st/th/8181779988280/2026/upi/9fa05160350e1d9e850bf29a0969fd5b/v1.5/CVS-Caremark-to-cover-Foundayo-Zepbound-obesity-drugs.jpg" /> CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.

Read full article at UPI →